Sun Pharma surges on launching Volini Maxx

29 Aug 2018 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 625.20, up by 4.00 points or 0.64% from its previous closing of Rs. 621.20 on the BSE.

The scrip opened at Rs. 623.00 and has touched a high and low of Rs. 630.50 and Rs. 623.00 respectively. So far 234321 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 645.00 on 23-Aug-2018 and a 52 week low of Rs. 434.80 on 22-May-2018.

Last one week high and low of the scrip stood at Rs. 645.00 and Rs. 618.65 respectively. The current market cap of the company is Rs. 150017.78 crore.

The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.98% and 12.64% respectively.

Sun Pharmaceutical Industries’ division Sun Pharma Consumer Healthcare has launched Volini Maxx, India’s strongest pain relief spray. The company has signed Virat Kohli, captain of Indian cricket team as the new brand ambassador of Volini.

Volini Maxx is a new variant of Sun Pharma’s popular brand and its unique formulation of 2% diclofenac makes it 100% stronger than the existing 1% diclofenac sprays available in the Indian market. Volini Maxx is targeted for severe pains including musculoskeletal, joint and low back.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.